Moreover, in October 2021, Cambrex announced that its manufacturing center of excellence in High Point, North Carolina, will be expanded. The investment of more than US$ 30 million is intended to fulfil the growing demand for small molecule development and production services. New chemical laboratories, two new clinical manufacturing sites, and a small-scale commercial manufacturing operation with three work centers and 2,000 liter reactors will also be part of the expansion.
A CAGR of 8.0% is anticipated for the global market for Manufacturing HPAPIs and Cytotoxic Medicines during the forecast period (2022-2030).
Key Companies in the HPAPIs and Cytotoxic Drugs Manufacturing Industry:
1) Teva Pharmaceutical Industries Ltd.: The Teva company is based in Tel Aviv, Israel. Based in Israel, Teva Pharmaceutical Industries Ltd. develops, produces, markets, and distributes generic drugs, novel pharmaceuticals, and biopharmaceuticals along with its subsidiaries and affiliated businesses. Founded in 1901.
2) Pfizer, Inc.: One of the biggest pharmaceutical companies in the world, Pfizer has annual sales of almost $50 billion (excluding COVID-19 product sales). While it traditionally sold several types of healthcare supplies and chemicals, presently, prescription medications and vaccines make for the majority of revenues. Pfizer completes the acquisition of Biohaven Pharmaceuticals in 2023. Headquarter in New York City, U.S.
3) Lonza Group: Known as a CDMO, Lonza Group is a contract development and manufacturing company. Small molecules, biologics, cell & gene, capsules & health ingredients, and these four segments make up its operations. Long-term supply contracts with pharmaceutical clients are the main source of income for Lonza. Gampel was established in 1897 in Gampel-Bratsch, Switzerland. Basel, Switzerland, as the main office. Lonza has made 4 investments and 11 acquisitions. The company has invested more than $6.50 billion in acquisitions. Lonza has made investments across a range of industries, including Life Sciences Platforms and Tools, Nutraceuticals Technology, Life Sciences Technology, and more.
4) CordenPharma International: The contract drug development and manufacturing business CordenPharma will be purchased by Astorg Partners. The deal's estimated value is $2.6 billion, according to reports. The International Chemical Investors Group is being acquired by the Paris-based company. CordenPharma's founders will reinvest in the business alongside Astorg as part of the agreement. created in 1970. Germany's Baden-Wurttemberg state is home to CordenPharma.
5) Evonik Industries AG: German chemical manufacturer Evonik Industries sells both speciality and common chemical products. In 80% of its businesses, it holds the number-one to third position in the market. German headquarters in Essen. Established on September 12, 2007. Evonik expands its offering of system solutions by purchasing cosmetic delivery firm Infinitec Activos.
6) Flamma Group: The Flamma Group offers a range of pharmaceutical services, such as process R&D, cGMP manufacture of APIs, RSMs, and NCEs. The main office of Flamma Group is situated at 196 Rue Houdan, Sceaux, Ile de France, 92330. Built in 1950. A new API site is acquired by FLAMMA GROUP in Italy.
*Definition: A class of medications called as cytotoxic drugs, also referred to as antineoplastics, are used to treat cancer because they include substances that are poisonous to cells and impede their replication or growth.
